Jagiellonian University has developed a sustainable biological method to manage sludge bulking and foaming in wastewater treatment plants. By using cultured Lecane inermis rotifers to naturally control filamentous bacteria, the technology improves sedimentation, reduces the need for harmful chemical agents, and lowers operational costs. The method is environmentally friendly, requires no complex infrastructure changes, and shows potential for microplastic aggregation. It is currently being implemented in full-scale facilities and is available for licensing.
The Jagiellonian University has developed an innovative biological method to address the excessive growth of filamentous bacteria in activated sludge, a critical operational challenge for wastewater treatment plants worldwide. Uncontrolled filamentous bacterial growth leads to sludge bulking and foaming, which reduces treatment efficiency, increases costs, and necessitates the use of potentially environmentally harmful chemical agents. This technology offers a sustainable, natural alternative by utilizing specific rotifers—microorganisms that naturally inhabit activated sludge—to control bacterial populations. Beyond managing sludge bulking, research indicates this approach may also assist in aggregating microplastics in wastewater, providing an additional environmental benefit.
The core of the technology relies on the cultivation and introduction of Lecane inermis rotifers into the activated sludge process. Key features and capabilities include:
The technology is assessed as TRL 8. It has progressed from laboratory-scale validation through testing in multiple full-scale municipal and industrial wastewater treatment plants. These implementations have...
Jagiellonian University is a comprehensive public research university in Krakow with a broad academic profile and an integrated medical college connected to a major hospital system. Industry partners engage through co-located core facilities, prototyping and analytical labs, and contract research, with access to a nearby research and technology park and startup incubation. Health system integration supports clinical research and translation with access to patient cohorts and regulated environments. Research is supported by competitive national funding and European Union programs, enabling collaborations that scale across borders. A dedicated technology transfer office manages IP, licensing, and spinout formation and offers industry-friendly agreements to streamline engagement.